Key result
BKPyV miRNA detection did not demonstrate additional diagnostic value compared to BKPyV DNA monitoring in kidney transplant recipients, with no significant difference in areas under the ROC curves.
Why the study?
Does BKPyV miRNA measurement have additional diagnostic and predictive value compared to BKPyV DNA monitoring in kidney transplant recipients?
Observational (n=30)
Does BKPyV miRNA measurement have additional diagnostic and predictive value compared to BKPyV DNA monitoring in kidney transplant recipients?
BKPyV miRNA detection does not provide additional diagnostic value over BKPyV DNA monitoring in the early phase after kidney transplantation.
Answers are grounded in this paper and cite their sources.
BKPyV miRNA offers no added diagnostic value over DNA loads in KTR; leaves open its predictive utility in larger prospective studies.
INTRODUCTION: It is unclear whether polyomavirus BK (BKPyV) microribonucleic acid (miRNA) measurement has additional diagnostic and predictive value in kidney transplant recipients (KTR) as compared to current methods of monitoring BKPyV DNA loads. PATIENTS AND METHODS: A retrospective, longitudinal study was performed in 30 KTR with BKPyV viruria (n = 10), BKPyV viremia (n = 10), or BKPyV-associated neuropathy (BKPyVAN) (n = 10). Bkv-miR-B1-3p and 5p and BKPyV DNA load were measured in urine and plasma and compared using receiver operating characteristic (ROC) curves. RESULTS: Levels of Bkv-miR-B1-3p and 5p and BKPyV DNA correlated strongly. Overall, mostly analog courses of urinary and plasma miRNA and DNA loads were observed. Areas under the ROC curves were not significantly different between miRNAs and DNA. Only, in contrast to BKPyV DNA load, BKPyV miRNA levels increased from 6 to 12 months in the viremia group, while in the BKPyVAN group, a decline was seen in both DNA and miRNA. CONCLUSIONS: In this study, we could not demonstrate an additional value of BKPyV miRNA detection compared to BKPyV DNA monitoring in the early phase after kidney transplantation. We did observe significant differences between the viremia and the BKPyVAN groups during follow-up. This study was performed with a small number of patients and therefore results should be verified in a larger patient cohort. Furthermore, future studies with larger patient groups are necessary to elucidate final clinical value of these data.
No takes yet. Share an insight, caveat, or question.
Doesum et al. (2022) conducted an observational in Kidney transplant recipients with BKPyV-related pathology (n=30). BKPyV miRNA measurement vs. BKPyV DNA load monitoring was evaluated on Diagnostic and predictive value (area under the ROC curve). BKPyV miRNA detection did not demonstrate additional diagnostic value compared to BKPyV DNA monitoring in kidney transplant recipients, with no significant difference in areas under the ROC curves.
Synapse has enriched 10 related papers. Consider them for comparative context: